Does Diabetes Related Distress Impact on Balance Glycemic ?

Diabetes Clinical Trial

— DDS  

Official title:

Does Diabetes Related Distress Impact on Balance Glycemic ?

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05831384
• Other study ID #: APHP230419
• Secondary ID: 2023-A00342-43
• Status: Completed
• Start date: May 11, 2023
• Est. completion date: May 30, 2023

Study information

• Verified date: August 2023
• Source: Assistance Publique - Hôpitaux de Paris
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The main objective is to assess the overall diabetes distress score in adult patients with diabetes during their hospitalization in a diabetes ward, using the Diabetes Distress Scale (DDS-17).

The correlation between the overall diabetes distress score and the patient's glycosylated haemoglobin will then be assessed.

Description:

The health consequences of emotional problems are associated with poor self-care behaviour, poor metabolic outcomes (HbA1c) and reduced quality of life. If quarterly glycated haemoglobin (HbA1c) testing is the gold standard for monitoring the risk of diabetes complications, should it not be systematically combined with the assessment of distress related to living with diabetes? To our knowledge, there are few studies in France that have correlated glycaemic control with a scale assessing the emotional stress factors associated with diabetes.

The main objective is to evaluate diabetes-related distress in adult patients with diabetes during their hospitalization in a diabetes ward, using a self-assessment instrument: the Diabetes Distress Scale (DDS-17).

The secondary objective is to assess the correlation between the overall diabetes distress score and the patient's glycosylated haemoglobin.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 66
• Est. completion date: May 30, 2023
• Est. primary completion date: May 30, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients living with type 1 or type 2 diabetes.

• Patients hospitalised in the diabetes department of the IE3M.

• Patients aged ? 18 years.

• Patients agreeing to participate in this study after information.

• Beneficiary of the health insurance.

Exclusion Criteria:

• Refusal to participate.

• Inability to communicate in French.

• Inability to read or write French.

• Communication disorders.

• History of psychiatric disorders, dementia.

• Patient under guardianship or curatorship.

• Patient not affiliated to social security.

• Patient affiliated to the Aide Médicale d'Etat (AME).

Related Conditions & MeSH terms

• Diabetes
• Diabetes Mellitus

Locations

Country	Name	City	State
France	Diabetology department - Hospital of Pitié Salpêtrière - APHP	Paris

Sponsors (1)

Lead Sponsor	Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Overall diabetes distress score	The primary endpoint is the overall diabetes distress score obtained by the DDS-17 psychometric tool. Each item is rated on a 6-point scale ranging from (1) "not a problem" to (6) "a very significant problem".; Each of the 17 criteria of the DDS17 is rated on a 6-point scale ranging from (1) "not a problem" to (6) "a very important problem".; The scale gives an overall distress score based on the average responses on the 1-6 scale for the 17 items.; Interpretation of the DDS 17 total scores: Mean score < 2.0 = reflects little or no distress; Mean score between 2.0 and 2.9 = reflects moderate distress; Mean score > 3.0 = reflects high distress.	at baseline
Secondary	The The patient's glycated haemoglobin (Hba1c) result, expressed as a %, taken during the standard check-up on the day of admission to hospital result (Hba1c)	The patient's glycated haemoglobin (Hba1c) result, expressed as a %, taken during the standard check-up on the day of admission to hospital.	at baseline